CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.
FASEB J
2019
33
2
1860-1872
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Ann Oncol
2019
30
12
1959-1968
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
N Engl J Med
2019
381
4
317-327
New wine into old wineskins: PGC-1α and NF-κB in obesity and acute pancreatitis.
J Pathol
2019
248
1
6-8
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB.
Cancers
2019
11
7
Olaparib as Maintenance Treatment Following First-line Platinum-based
Chemotherapy (PBC) in Patients With a Germline BRCA Mutation and
Metastatic Pancreatic Cancer (mPC): Phase III POLO Trial
Pancreas
2019
48
10
1433-1434
Palliative chemotherapy in pancreatic cancer-treatment sequences.
Transl Gastroenterol Hepatol
2019
4
Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial.
Ann Oncol
2019
30 Suppl 4